Message Image

Skip main navigation (Press Enter).

Diabetes Technology News

Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
- June 10, 2024
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
- May 29, 2024
FDA approves hybrid closed-loop insulin delivery app from CamDiab
- May 24, 2024
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
- March 18, 2024
FDA Clears First Over-the-Counter Continuous Glucose Monitor
- March 5, 2024
Tandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery System
- February 2024
Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor
- January 2024
Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas with Dexcom G7 CGM System
- December 2023
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.
- December 2023
Omnipod® 5 App for iPhone now has FDA clearance
- October 2023
Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design
- September 2023
Abbott To Acquire Bigfoot Biomedical, Furthering Efforts To Develop Personalized, Connected Solutions For People With Diabetes
- September 2023
Welldoc Receives 11th 510(k) Clearance from FDA for Award-Winning Diabetes Platform BlueStar®
- August 2023
The Accu-Chek Solo micropump system received 510(k) clearance
- August 2023
Tandem Mobi, World’s Smallest Durable Insulin Delivery System, Receives FDA Clearance
- July 2023
Beta Bionics Announces FDA Clearance for the use of a Prefilled Insulin Cartridge with the iLet Bionic Pancreas
- June 2023
Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod
- April 25, 2023
Lilly to Divest BAQSIMI to Amphastar
- April 24, 2023
FDA Approves Medtronic MiniMed™ 780G System
- April 21, 2023
FDA Clears Reader For Abbott's Freestlye Libre® 3 System
- April 14, 2023
Insulin Price Cuts
- March 16, 2023
U.S. FDA Clears Abbott's Freestyle Libre® 2 And Freestyle Libre® 3 Sensors For Integration With Automated Insulin Delivery Systems
- March 6, 2023
Medicare to expand CGM coverage to more Type 2 diabetes patients (MedtechDive)
- March 2, 2023
Bigfoot Biomedical Receives FDA Clearance for Bigfoot Unity® Android App for People Living with Insulin-Requiring Diabetes
- March 2, 2023
Standards of Care Begin to Reflect Advances in Diabetes Technology
- February 14, 2023
Diabetes Technology: FDA Approves Abbott's Spinal Cord Stimulation for People Living with Diabetes
- January 26, 2023
New HHS Report Finds Major Savings for Americans Who Use Insulin
- January 24, 2023
Tidepool Loop Receives FDA Clearance
- January 24, 2023
FDA approves once-weekly Wegovy injection for the treatment of obesity in teens aged 12 years and older
- December 23, 2022
Dexcom G7 Now FDA Approved!
- December 8, 2022
Medtronic Extended infusion set and reservoir
- November 22, 2022
Freestyle Libre 3 Now Available in Pharmacies Across the U.S.
- October 6, 2022
Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)
- September 7, 2022
Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
- August 22, 2022
Tandem lines up FDA review of new pint-sized insulin pump amid lower-than-expected sales
- August 4, 2022
Mobile Bolus feature now available for Tandem t:slim X2 pump users with a compatible smartphone
- July 2022
Libre 3 now FDA approved
- May 31, 2022
Sugar.IQ™ App Discontinuation (Medtronic Guardian™ Connect System)
- March 30, 2022
Dexcom G7 received CE mark
- March 14, 2022
First Smartphone App FDA cleared for Insulin Delivery on Both iOS and Android Operating Systems
- February 16, 2022
Insulet Promotes Inclusivity for People with Diabetes through Nintendo® Video Game Animal Crossing™: New Horizons
- February 16, 2022
Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months
- February 11, 2022
Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control
- January 28, 2022
New FDA Approved Insulin Marks Another Win for Insulin Affordability
- January 3, 2022
Digitizing Diabetes Management with T1D Apps
- December 16, 2021
Racial disparities in diabetes technology use widen among Medicare beneficiaries
- December 15, 2021
Tandem Diabetes Care Plans for Future with Technology Choices
- December 8, 2021
Get Up Close and in the Know with Sean Salmon, President of Medtronic Diabetes
- December 5, 2021
Mobile App Interventions to Improve Medication Adherence Among Type 2 Diabetes Mellitus Patients: A Systematic Review of Clinical Trials
- December 3, 2021
CGM as medicine: Technology benefits extend to type 2 diabetes
- November 22, 2021
U.S. House votes to cap insulin cost at $35 per month
- November 19, 2021
After another successful quarter, diabetes tech players look ahead to key product launches
- November 11, 2021
Status Update: Connected Insulin Delivery Devices
- October 2021
Resources: Connected Insulin Delivery Devices
- October 2021
What's in Your Diabetes Toolkit?
- October 13, 2021
Highlights from EASD 2021
- October 2, 2021
Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use
- September 24, 2021
Status Update: Automated Insulin Delivery Devices
- August 2021
FDA Approves 7-day Infusion Set
- August 30, 2021
What Are the Best Apps Out There for Improving Your Health?
- August 23, 2021
New diabetes technology is expected to improve customization, availability of real-time data
- August 16, 2021
Newest Updates in Diabetes Care and Education from ADCES 2021
- August 16, 2021
Embrace diabetes apps as part of a technology-enabled practice
- August 15, 2021
Technology Disparities and Therapeutic Inertia: A Call to Action for the Diabetes Care and Education Specialist
- August 5, 2021
FDA Approves Exenatide for Children and Teens with Type 2 Diabetes
- August 2, 2021
Abbott's Freestyle® Libre 2 iOS app cleared in U.S.
- August 2, 2021
8 Great CGM and Insulin Pump Patches for People with Diabetes
- July 8, 2021
Highlights of the American Diabetes Association’s 2021 Annual Meeting
- July 6, 2021
What You Should Know About Walmart’s Newest Low-Cost Insulin
- June 30, 2021
Policy Change Allows Approval For Medicare Patients Living With Diabetes To Use Both Afrezza® And Continuous Glucose Monitoring Devices Beginning July 18
- June 28, 2021
Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan
- June 26, 2021
The Latest News in Diabetes Technology – More from ATTD 2021
- June 7, 2021
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
- June 4, 2021
Senseonics Announces Results of the PROMISE Study Demonstrating Strong Accuracy of 180 Day CGM Sensor
- June 3, 2021
The Biggest News in Diabetes Technology: Opening Day at ATTD 2021
- June 2, 2021
Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Management System
- May 10, 2021
Bigfoot Biomedical® Receives FDA Clearance for Bigfoot Unity™ Diabetes Management System
- May 6, 2021

Contact Us

Academy of Nutrition and Dietetics

120 South Riverside Plaza, Suite 2190

Chicago, Illinois 60606-6995

(312) 899-0040

DiabetesPracticeGroup@eatright.org

Privacy & Terms

Terms of Use
Accessibility

Quick Links

Copyright 2024 eatright.org. Academy of Nutrition and Dietetics. All rights reserved.

Copyright 2025 eatright.org. Academy of Nutrition and Dietetics. All rights reserved.

Powered by Higher Logic